Quantity
Single
Pack of 3
Pack of 6
Tirzepatide
Order Now, Ships Today
$145
$130
One-time
Add To Cart
Research Use Only
Research Use Only - All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Certificate of Analysis
Certificate of Analysis - Third-party tested for 99% purity, ID, quantity.
Tirzepatide
Overview
Tirzepatide is a synthetic peptide that functions as a dual agonist for both glucagonlike peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This unique mechanism of action allows for the modulation of glucose regulation and metabolic processes. Research indicates its potential in studies related to glucose homeostasis and body weight management. Its peptide structure is engineered to activate key receptors involved in metabolic control.
History
Tirzepatide’s development marks a significant advancement in metabolic research, emerging as a novel dual GIP and GLP-1 receptor agonist. Its preclinical discovery and subsequent clinical evaluation have focused on addressing challenges in glycemic control and obesity. The compound has undergone extensive clinical trial programs, leading to its approval for therapeutic use in type 2 diabetes and obesity.
Tirzepatide
Structure
Molecular Formula:
C225H348N48O68
Molecular Weight:
4813.0 g/mol
PubChem ID:
156588324
Research Findings
Obesity and type 2 diabetes mellitus (T2DM) are intertwined epidemics that continue to pose significant challenges to global public health. Tirzepatide, a dual GIP and GLP1 receptor agonist, has demonstrated multifaceted metabolic effects, making it a promising agent for addressing both conditions. Research has focused on its impact across several key areas.
Key Areas of Research:
Weight Management: significant weight reduction, fat mass reduction, maintenance of lost weight
Appetite Regulation: reduced food intake, decreased overall appetite scores, increased satiety and fullness
Glycemic Control: improved glycemic control, notable reductions in HbA1c levels, reduced fasting and postprandial glucose
Lipid Profile Modulation: beneficial impact on lipid profile, reductions in total cholesterol, LDL-C, triglycerides, increased HDL-C
Overall, Tirzepatide exhibits multifaceted metabolic benefits with a manageable adverse profile, positioning it as a promising agent for obesity and type 2 diabetes research. Continued investigation into its long-term efficacy and safety in diverse populations is ongoing.
Our Process
Text us, our dedicated team is here to help
Reach out and get a response within minutes.
Frequently Asked Questions
All products are for research use only. Third-party testes for 99%+ purity.
